Diversity of vaginal microbiome and metabolome during genital infections/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Claregrieve1 on 2023-5-22

Curated date: 2023/03/08

Curator: Danyab56

Revision editor(s): LGeistlinger, Claregrieve1, Danyab56

Subjects

Location of subjects
Italy
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Vagina Vagina,vagina,Distal oviductal region,Distal portion of oviduct,Vaginae
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Chlamydia trachomatis infectious disease chlamydia,Chlamydia Infections,Chlamydia trachomatis caused disease or disorder,Chlamydia trachomatis disease or disorder,Chlamydia trachomatis infectious disease,chlamydia trachomatis infectious disease,chlamydial disease,Chlamydial Infection,Chlamydial infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Chlamydia trachomatis
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
‘Chlamydia’ (CT) (detection of C. trachomatis DNA by Versant CT/GC DNA 1.0 Assay)
Group 0 sample size Number of subjects in the control (unexposed) group
21
Group 1 sample size Number of subjects in the case (exposed) group
20
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
n/a

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Kruskall-Wallis
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Richness Number of species
unchanged
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Reviewed Marked as Reviewed by Claregrieve1 on 2023-5-22

Curated date: 2023/03/09

Curator: Danyab56

Revision editor(s): Danyab56, Aiyshaaaa, Claregrieve1

Source: Table 2

Description: Differential microbial abundance between controls and chlamydia subjects

Abundance in Group 1: increased abundance in Chlamydia trachomatis

NCBI Quality ControlLinks
Aerococcaceae
Aerococcus
Alloscardovia
Atopobium
Bifidobacteriaceae
Blautia
Clostridiaceae
Clostridium
Coriobacteriaceae
Dialister
Escherichia
Faecalibacterium
Lachnospiraceae
Megasphaera
Oscillospiraceae
Roseburia
Sneathia
Streptococcus
Ureaplasma
Veillonellaceae
unclassified Coriobacteriaceae
unclassified Lachnospiraceae
Bifidobacterium

Revision editor(s): Danyab56, Aiyshaaaa, Claregrieve1